<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03743311</url>
  </required_header>
  <id_info>
    <org_study_id>IC4 -05682-058-RUS</org_study_id>
    <nct_id>NCT03743311</nct_id>
  </id_info>
  <brief_title>Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease</brief_title>
  <acronym>EQUALISER</acronym>
  <official_title>The Russian Multicenter Observational Program Obtaining of Data on the Impact of Different Treatment Modalities on the Quality of Life of the Patients With Acute and Chronic Hemorrhoid Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Servier Russia</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Servier Russia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The program is aimed at obtaining data on the impact of the method and type of treatment on&#xD;
      the quality of life of patients with acute or chronic hemorrhoids with option of conservative&#xD;
      treatment with Detralex&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Changes in the quality of life of patients suffering from acute or chronic hemorrhoids within&#xD;
      1 month after presenting to a doctor, in general population and in specific demographic and&#xD;
      clinical groups.&#xD;
&#xD;
      The program included patients who presented to a doctor for acute or chronic hemorrhoids. All&#xD;
      the treatment was fully compliant with the conventional clinical practice, instructions for&#xD;
      medical use of drugs and a specific clinical situation. The standard parameters usually&#xD;
      evaluated in patients with hemorrhoids were studied during the program. In addition, at the&#xD;
      first visit to the doctor and at the end of the study, the patient filled out an SF-36&#xD;
      questionnaire for assessing the QoL&#xD;
&#xD;
      The general population of patients included in the program, the following three groups of&#xD;
      patients were considered:&#xD;
&#xD;
        -  Group 1, with only conservative (medical) therapy during the study;&#xD;
&#xD;
        -  Group 2, with conservative (medical) therapy and additional minimally invasive procedure&#xD;
           during the study (no surgery);&#xD;
&#xD;
        -  Group 3, with conservative (medical) therapy and additional surgery for hemorrhoids&#xD;
           during the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Actual">June 5, 2019</completion_date>
  <primary_completion_date type="Actual">June 5, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)</measure>
    <time_frame>1 month after presenting to a doctor</time_frame>
    <description>The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients</measure>
    <time_frame>1 month after presenting to a doctor</time_frame>
    <description>QoL assessment using the SF36 scale questioner ( assessment of QoL quastions) - added to the Referance The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">1032</enrollment>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Surgical treatment of Hemmorhoid</arm_group_label>
    <description>Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conservative treatment of Hemmorhoid</arm_group_label>
    <description>Patients taken conservative treatment (Detralex)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combined treatment of Hemmorhoid</arm_group_label>
    <description>Combined treatment patients (surgery and conservative treatment)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hemorrhoidectomy, Thrombectomy , Operation on Longo method</intervention_name>
    <description>Surgical procedures for treatment of Hemorhoid</description>
    <arm_group_label>Surgical treatment of Hemmorhoid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Detralex</intervention_name>
    <description>Conservative treatment of Hemorhoid</description>
    <arm_group_label>Conservative treatment of Hemmorhoid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Combined therapy</intervention_name>
    <description>Surgical + conservative treatment of Hemorhoid</description>
    <arm_group_label>Combined treatment of Hemmorhoid</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with acute or chronic hemorrhoids.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age over 18 years;&#xD;
&#xD;
          2. Providing written information to a patient about inclusion in the program, and his/her&#xD;
             consent to participate in it,&#xD;
&#xD;
          3. Absence of conditions requiring urgent medical care and not related to hemorrhoids;&#xD;
&#xD;
          4. The patient was diagnosed with:&#xD;
&#xD;
               -  Acute hemorrhoids;&#xD;
&#xD;
               -  Exacerbation of chronic hemorrhoids;&#xD;
&#xD;
               -  Chronic hemorrhoids&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. The patient is consulting for an urgent issue not related to hemorrhoids;&#xD;
&#xD;
          2. The presence of severe systemic diseases;&#xD;
&#xD;
          3. Pregnancy;&#xD;
&#xD;
          4. Inability to understand the meaning of the Program and follow the doctor's&#xD;
             recommendations&#xD;
&#xD;
          5. Patients with inflammatory bowel diseases&#xD;
&#xD;
          6. Patients with concomitant diseases of the anal canal&#xD;
&#xD;
          7. Patients taking anticoagulants;&#xD;
&#xD;
          8. Patients with previous anorectal surgeries, including hemorrhoidectomy or excision of&#xD;
             anal fistula.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olga LINNIK</last_name>
    <role>Study Chair</role>
  </overall_official>
  <location>
    <facility>
      <name>Pirogov National Surgery Center</name>
      <address>
        <city>Moscow</city>
        <state>Pervomaisrfya 70</state>
        <zip>105203</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>November 13, 2018</study_first_submitted>
  <study_first_submitted_qc>November 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2018</study_first_posted>
  <results_first_submitted>December 4, 2020</results_first_submitted>
  <results_first_submitted_qc>March 23, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 29, 2021</results_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <study_docs>
    <study_doc>
      <doc_type>the SF36 scale questioner</doc_type>
      <doc_url>https://clinmedjournals.org/articles/jmdt/jmdt-2-023-figure-1.pdf</doc_url>
      <doc_comment>The scale the SF36 scale questioner can be sent by email.</doc_comment>
    </study_doc>
  </study_docs>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT03743311/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/11/NCT03743311/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Conservative Treatment of Hemmorhoid</title>
          <description>Patients taken conservative treatment (Detralex)&#xD;
Detralex: Conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="P2">
          <title>Combined Treatment of Hemmorhoid</title>
          <description>Combined treatment patients (surgery and conservative treatment)&#xD;
Combined therapy: Surgical + conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="P3">
          <title>Surgical Treatment of Hemmorhoid</title>
          <description>Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)&#xD;
Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="311"/>
                <participants group_id="P2" count="298"/>
                <participants group_id="P3" count="423"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="311"/>
                <participants group_id="P2" count="298"/>
                <participants group_id="P3" count="423"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Conservative Treatment of Hemmorhoid</title>
          <description>Patients taken conservative treatment (Detralex)&#xD;
Detralex: Conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="B2">
          <title>Combined Treatment of Hemmorhoid</title>
          <description>Combined treatment patients (surgery and conservative treatment)&#xD;
Combined therapy: Surgical + conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="B3">
          <title>Surgical Treatment of Hemmorhoid</title>
          <description>Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)&#xD;
Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="311"/>
            <count group_id="B2" value="298"/>
            <count group_id="B3" value="423"/>
            <count group_id="B4" value="1032"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="311"/>
                    <count group_id="B2" value="298"/>
                    <count group_id="B3" value="423"/>
                    <count group_id="B4" value="1032"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="289"/>
                    <measurement group_id="B2" value="274"/>
                    <measurement group_id="B3" value="396"/>
                    <measurement group_id="B4" value="959"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="27"/>
                    <measurement group_id="B4" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="311"/>
                    <count group_id="B2" value="298"/>
                    <count group_id="B3" value="423"/>
                    <count group_id="B4" value="1032"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42.9" lower_limit="18" upper_limit="90"/>
                    <measurement group_id="B2" value="44.2" lower_limit="19" upper_limit="78"/>
                    <measurement group_id="B3" value="46.9" lower_limit="20" upper_limit="94"/>
                    <measurement group_id="B4" value="44.9" lower_limit="18" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <population>There is no data about sex of 2 participants in Group 1 There is no data about sex of 3 participants in Group 3</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="309"/>
                    <count group_id="B2" value="298"/>
                    <count group_id="B3" value="420"/>
                    <count group_id="B4" value="1027"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="171"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="209"/>
                    <measurement group_id="B4" value="519"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="138"/>
                    <measurement group_id="B2" value="159"/>
                    <measurement group_id="B3" value="211"/>
                    <measurement group_id="B4" value="508"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Russia</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="311"/>
                    <count group_id="B2" value="298"/>
                    <count group_id="B3" value="423"/>
                    <count group_id="B4" value="1032"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="311"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="423"/>
                    <measurement group_id="B4" value="1032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>patients with acute or chronic hemorrhoids</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="311"/>
                    <count group_id="B2" value="298"/>
                    <count group_id="B3" value="423"/>
                    <count group_id="B4" value="1032"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="311"/>
                    <measurement group_id="B2" value="298"/>
                    <measurement group_id="B3" value="423"/>
                    <measurement group_id="B4" value="1032"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)</title>
        <description>The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
        <time_frame>1 month after presenting to a doctor</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Surgical Treatment of Hemmorhoid</title>
            <description>Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)&#xD;
Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid</description>
          </group>
          <group group_id="O2">
            <title>Conservative Treatment of Hemmorhoid</title>
            <description>Patients taken conservative treatment (Detralex)&#xD;
Detralex: Conservative treatment of Hemorhoid</description>
          </group>
          <group group_id="O3">
            <title>Combined Treatment of Hemmorhoid</title>
            <description>Combined treatment patients (surgery and conservative treatment)&#xD;
Combined therapy: Surgical + conservative treatment of Hemorhoid</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in the Quality of Life of Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor (Visit V0 vs Visit3)</title>
          <description>The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="298"/>
                <count group_id="O3" value="423"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.5" lower_limit="3.4" upper_limit="29.6"/>
                    <measurement group_id="O2" value="11.1" lower_limit="2.7" upper_limit="19.5"/>
                    <measurement group_id="O3" value="13.7" lower_limit="6.4" upper_limit="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" lower_limit="10" upper_limit="21"/>
                    <measurement group_id="O2" value="6.5" lower_limit="3.8" upper_limit="9.2"/>
                    <measurement group_id="O3" value="6.3" lower_limit="6" upper_limit="6.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19.8" lower_limit="13.2" upper_limit="26.4"/>
                    <measurement group_id="O2" value="3.9" lower_limit="0.5" upper_limit="7.3"/>
                    <measurement group_id="O3" value="1.8" lower_limit="1" upper_limit="4.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General health</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13" lower_limit="6.4" upper_limit="19.6"/>
                    <measurement group_id="O2" value="9.7" lower_limit="8.2" upper_limit="11.2"/>
                    <measurement group_id="O3" value="11.6" lower_limit="9.1" upper_limit="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" lower_limit="5" upper_limit="9.4"/>
                    <measurement group_id="O2" value="3.9" lower_limit="2.2" upper_limit="5.6"/>
                    <measurement group_id="O3" value="6.5" lower_limit="4.9" upper_limit="8.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.4" lower_limit="9.2" upper_limit="27.6"/>
                    <measurement group_id="O2" value="10.4" lower_limit="5.2" upper_limit="15.6"/>
                    <measurement group_id="O3" value="8.2" lower_limit="5.3" upper_limit="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role emotional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.4" lower_limit="17.9" upper_limit="42.9"/>
                    <measurement group_id="O2" value="12.8" lower_limit="5.5" upper_limit="18.5"/>
                    <measurement group_id="O3" value="11.4" lower_limit="8.5" upper_limit="14.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental health</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.4" lower_limit="8.3" upper_limit="20.5"/>
                    <measurement group_id="O2" value="8.7" lower_limit="5.6" upper_limit="11.8"/>
                    <measurement group_id="O3" value="11" lower_limit="6.3" upper_limit="15.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients</title>
        <description>QoL assessment using the SF36 scale questioner ( assessment of QoL quastions) - added to the Referance The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
        <time_frame>1 month after presenting to a doctor</time_frame>
        <group_list>
          <group group_id="O1">
            <title>All Patients Suffering From Acute or Chronic Hemorrhoids Within 1 Month After Presenting to a Doctor</title>
            <description>All groups of patients suffering from acute or chronic hemorrhoids within 1 month after presenting to a doctor (medical therapy, minimally invasive procedures, and surgical interventions)</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in the Quality of Life During the Treatment (Visit V0 vs Visit V3) Based on Results of All Groups of Patients</title>
          <description>QoL assessment using the SF36 scale questioner ( assessment of QoL quastions) - added to the Referance The Short Form (36) Health Survey (SF36 ) scale questioner was used. SF36 is is a 36-item, patient-reported survey of patient health. The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1032"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physical functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.8" lower_limit="5.6" upper_limit="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role physical</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.2" lower_limit="7.6" upper_limit="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bodily pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.8" lower_limit="5.4" upper_limit="12.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>General health</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5" lower_limit="8.9" upper_limit="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Vitality</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="4.1" upper_limit="7.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Social functioning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12" lower_limit="6.8" upper_limit="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mental health</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.4" lower_limit="6.7" upper_limit="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Role emotional</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.5" lower_limit="11.4" upper_limit="23.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Conservative Treatment of Hemmorhoid</title>
          <description>Patients taken conservative treatment (Detralex)&#xD;
Detralex: Conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="E2">
          <title>Combined Treatment of Hemmorhoid</title>
          <description>Combined treatment patients (surgery and conservative treatment)&#xD;
Combined therapy: Surgical + conservative treatment of Hemorhoid</description>
        </group>
        <group group_id="E3">
          <title>Surgical Treatment of Hemmorhoid</title>
          <description>Patients after surgical treatment (Instrumental Invasive Surgical Procedures or Thrombectomy, Hemorrhoidectomy etc.)&#xD;
Hemorrhoidectomy, Thrombectomy , Operation on Longo method: Surgical procedures for treatment of Hemorhoid</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="423"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="423"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <description>Diarrhea was considered as serious (medically significant) as it resulted in worsening of post-operative healing and increase of pain syndrome.</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="423"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="311"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="298"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="423"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Olga Linnik</name_or_title>
      <organization>AO Servier</organization>
      <phone>+7 495 9370700</phone>
      <email>olga.linnik@servier.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

